High-Quality Colonoscopic Surveillance Reveals Distinct Neoplasia Patterns in Lynch Syndrome : Gut | May 2026

Introduction

Lynch Syndrome remains the most common inherited colorectal cancer predisposition syndrome and is associated with markedly elevated lifetime risk of Colorectal Cancer. High-quality colonoscopic surveillance is central to cancer prevention and early detection in Lynch syndrome, yet much of the historical evidence guiding surveillance intervals and risk stratification derives from cohorts with variable colonoscopy quality standards.

Problem Statement

Reliable genotype-specific neoplasia detection data from modern high-quality surveillance programs remain limited. Understanding lesion characteristics and risk factors within optimized surveillance settings is essential for refining precision surveillance strategies in Lynch syndrome.

Summary

This tertiary-center study evaluated nearly 1,000 surveillance colonoscopies performed in patients with Lynch syndrome under exceptionally high-quality colonoscopy standards. The cohort achieved excellent procedural metrics, including very high caecal intubation and bowel preparation adequacy rates, providing a robust framework for accurate neoplasia detection analysis.

The study demonstrated a substantial adenoma burden, with adenomas detected in nearly one-third of surveillance procedures. Importantly, most adenomas were located in the proximal colon, reinforcing the well-established right-sided predominance of neoplasia in Lynch syndrome and highlighting the necessity of meticulous proximal colonic examination during surveillance.

A notable finding was the predominance of non-advanced and flat adenomas. Flat morphology can make lesions more difficult to detect, emphasizing the importance of optimized withdrawal technique, adequate inspection time and enhanced endoscopic vigilance in hereditary cancer surveillance programs.

Despite lower adenoma detection rates in carriers of MLH1 Mutation, this subgroup accounted for half of all colorectal cancers identified. This suggests that carcinogenesis in MLH1-associated Lynch syndrome may proceed more rapidly or through biologically aggressive pathways, potentially narrowing the window for adenoma detection before malignant transformation.

Conversely, higher serrated lesion detection rates were observed among MSH6 and PMS2 carriers, suggesting important genotype-specific differences in neoplastic pathways. These findings support the emerging concept that Lynch syndrome is not a single biologic entity but rather a spectrum of molecularly distinct syndromes with differing carcinogenic trajectories.

Several clinical factors influenced neoplasia detection. Older age and elevated body mass index were associated with higher adenoma detection rates, while male sex and non-white ethnicity were associated with increased colorectal cancer detection. These observations may help refine individualized surveillance intensity and risk stratification approaches.

The study is particularly important because it evaluates surveillance outcomes under modern quality benchmarks. Historically reported interval cancer rates and lesion detection patterns may have been confounded by suboptimal bowel preparation, incomplete examinations or inconsistent withdrawal practices. This work demonstrates that even within high-quality surveillance systems, substantial neoplastic burden persists in Lynch syndrome patients.

Clinically, the findings strongly support continued emphasis on colonoscopy quality metrics within hereditary cancer surveillance programs. High-definition imaging, careful proximal inspection and detection of subtle flat lesions remain critical. The data additionally strengthen the rationale for genotype-tailored surveillance protocols rather than uniform surveillance intervals across all mismatch repair gene carriers.

The observation that MLH1 carriers developed disproportionate colorectal cancer burden despite lower adenoma detection may eventually justify even more intensive surveillance strategies or adjunctive preventive approaches in selected high-risk genotypes.

Overall, this study demonstrates that patients with Lynch syndrome continue to harbor substantial colorectal neoplastic burden despite high-quality surveillance. The findings highlight distinct genotype-specific phenotypes, proximal and flat lesion predominance, and the importance of precision surveillance strategies guided by both colonoscopy quality and underlying mismatch repair genotype biology.